unaudited Financial result for the quarter and nine months ended 31st December, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pentokey Organy India reported unusual Q3 FY26 numbers, with revenue from operations showing a negative figure of Rs (209.14) Lakhs, likely reflecting large sales returns or reversals in its pharma/pesticides trading segment. This pushed the company into a quarterly loss of Rs 29.30 Lakhs, compared to a profit of Rs 14.23 Lakhs in the previous quarter (Q2 FY26) and Rs 3.78 Lakhs in the year-ago quarter (Q3 FY25). On a cumulative nine-month basis, however, revenue jumped sharply to Rs 395.39 Lakhs from Rs 22.00 Lakhs a year earlier, and profit before tax rose to Rs 33.41 Lakhs from Rs 18.90 Lakhs. The statutory auditor (Verma Mehta & Associates) issued an unmodified (clean) limited review report. The company also disclosed an outstanding income tax demand of Rs 171.58 Lakhs for AY 2015-16, which is under appeal and pending.
The negative Q3 revenue and swing to a loss are red flags that may concern investors, as they suggest significant reversals or weak sales execution in the most recent quarter despite strong nine-month cumulative growth. The pending Rs 171.58 Lakhs tax demand remains a contingent liability risk, though the clean auditor report and rising nine-month profits provide some reassurance.